In a study from our group, serum Sema3E levels were found not only to be increased in SSc patients compared to healthy individuals, but also to positively correlate with the early NVC pattern and the absence of DUs, suggesting that Sema3E might represent a biomarker of early vascular involvement [121]. The gene discussed is SEMA3E; the disease is systemic sclerosis.